Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
Kowdley, Kris V, Dr, Lawitz, Eric, MD, Crespo, Israel, MD, Hassanein, Tarek, MD, Davis, Mitchell N, MD, DeMicco, Michael, MD, Bernstein, David E, MD, Afdhal, Nezam, MD, Vierling, John M, MD, Gordon, Stuart C, MD, Anderson, Jane K, PhD, Hyland, Robert H, DPhil, Dvory-Sobol, Hadas, PhD, An, Di, PhD, Hindes, Robert G, MD, Albanis, Efsevia, MD, Symonds, William T, PharmD, Berrey, M Michelle, MD, Nelson, David R, MD, Jacobson, Ira M, MD
Published in The Lancet (British edition) (15.06.2013)
Published in The Lancet (British edition) (15.06.2013)
Get full text
Journal Article
Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma
Shaikh, Anjiya, Goli, Karthik, Rich, Nicole E, Benhammou, Jihane N, Khaderi, Saira, Hernaez, Ruben, Agopian, Vatche G, Vierling, John M, Kim, Donghee, Ahmed, Aijaz, Goss, John A, Rana, Abbas, Kanwal, Fasiha, Cholankeril, George
Published in Transplantation direct (01.05.2022)
Published in Transplantation direct (01.05.2022)
Get full text
Journal Article